• Türkçe
    • English
    • Deutsch
  • English 
    • Türkçe
    • English
    • Deutsch
  • Login
Search 
  •   DSpace Home
  • Fakülteler / Faculties
  • Search
  •   DSpace Home
  • Fakülteler / Faculties
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

xmlui.mirage2.discovery.showAdvancedFiltersxmlui.mirage2.discovery.hideAdvancedFilters

Filters

Use filters to refine the search results.

Now showing items 1-1 of 1

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
untranslated

Comparison of stage III mucinous and serous ovarian cancer: a case-control study 

Ayhan, Ali; Cuylan, Zeliha Fırat; Karabuk, Emine; Oz, Murat; Turan, Ahmet Taner; Meydanli, Mehmet M.; Taskin, Salih; Sari, Mustafa Erkan; Sahin, Hanifi; Ulukent, Suat C.; Akbayir, Ozgur; Gungorduk, Kemal; Gungor, Tayfun; Kose, Mehmet F. (2018)
Background: The purpose of this case-control study was to compare the prognoses of women with stage III mucinous ovarian carcinoma (MOC) who received maximal or optimal cytoreduction followed by paclitaxel plus carboplatin ...

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


Politika
Kullanıcı Rehberi
Başkent Üniversitesi Kütüphanesi
Başkent Üniversitesi

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeLanguageThis CommunityBy Issue DateAuthorsTitlesSubjectsTypeLanguage

My Account

LoginRegister

Discover

Author
Akbayir, Ozgur (1)
Ayhan, Ali (1)Cuylan, Zeliha Fırat (1)
Gungor, Tayfun (1)
Gungorduk, Kemal (1)Karabuk, Emine (1)Kose, Mehmet F. (1)Meydanli, Mehmet M. (1)Oz, Murat (1)Sahin, Hanifi (1)... View MoreSubject
Analyses (1)
Epithelial ovarian cancer (1)Mucinous adenocarcinoma (1)Serous cystadenocarcinoma (1)Survival (1)... View MoreDate Issued
2018 (1)

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV